Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I De Bock

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Journal of Diabetes Science and Technology|May 11, 2026
Diabetic Retinopathy Outcomes and Early Worsening of Diabetic Retinopathy in Adolescents and Young Adults With Type 1 Diabetes Following Rapid and Large Glycemic Improvements After Commencing Automated Insulin DeliveryWipa Warunyuwong, Alisa Boucsein, Kate M B Sneddon, et al.
Diabetes Care|February 13, 2021
Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 DiabetesOlivia J Collyns, Renee A Meier, Zara L Betts, et al.
Journal of Diabetes Science and Technology|November 14, 2025
Fully Closed-Loop Insulin Delivery with High-Carbohydrate and High-Fat Meals Using the Tandem Freedom SystemTom M Wilkinson, Martin I de Bock, Renee Meier, et al.
Acta Diabetologica|August 28, 2021
Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trialBenjamin J Wheeler, Olivia J Collyns, Renee A Meier, et al.
The New England Journal of Medicine|September 7, 2022
Open-Source Automated Insulin Delivery in Type 1 DiabetesMercedes J Burnside, Dana M Lewis, Hamish R Crocket, et al.
Diabetes Technology & Therapeutics|February 10, 2023
Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled TrialMercedes J Burnside, Dana M Lewis, Hamish R Crocket, et al.
Diabetes Technology & Therapeutics|May 25, 2017
Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose SuspendAnneke Graf, Glenn M Ward, Sara Vogrin, et al.
Diabetes Technology & Therapeutics|November 12, 2016
Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover StudyAmin Sharifi, Martin I De Bock, Dilshani Jayawardene, et al.
Diabetes Research and Clinical Practice|August 29, 2021
Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provisionJean C Lu, Sara Vogrin, Sybil A McAuley, et al.
Diabetes Technology & Therapeutics|December 22, 2020
Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily InjectionsSybil A McAuley, Sara Vogrin, Melissa H Lee, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Diabetes Science and Technology|May 11, 2026
Diabetic Retinopathy Outcomes and Early Worsening of Diabetic Retinopathy in Adolescents and Young Adults With Type 1 Diabetes Following Rapid and Large Glycemic Improvements After Commencing Automated Insulin DeliveryWipa Warunyuwong, Alisa Boucsein, Kate M B Sneddon, et al.
Diabetes Care|February 13, 2021
Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 DiabetesOlivia J Collyns, Renee A Meier, Zara L Betts, et al.
Journal of Diabetes Science and Technology|November 14, 2025
Fully Closed-Loop Insulin Delivery with High-Carbohydrate and High-Fat Meals Using the Tandem Freedom SystemTom M Wilkinson, Martin I de Bock, Renee Meier, et al.
Acta Diabetologica|August 28, 2021
Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trialBenjamin J Wheeler, Olivia J Collyns, Renee A Meier, et al.
The New England Journal of Medicine|September 7, 2022
Open-Source Automated Insulin Delivery in Type 1 DiabetesMercedes J Burnside, Dana M Lewis, Hamish R Crocket, et al.
Diabetes Technology & Therapeutics|February 10, 2023
Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled TrialMercedes J Burnside, Dana M Lewis, Hamish R Crocket, et al.
Diabetes Technology & Therapeutics|May 25, 2017
Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose SuspendAnneke Graf, Glenn M Ward, Sara Vogrin, et al.
Diabetes Technology & Therapeutics|November 12, 2016
Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover StudyAmin Sharifi, Martin I De Bock, Dilshani Jayawardene, et al.
Diabetes Research and Clinical Practice|August 29, 2021
Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provisionJean C Lu, Sara Vogrin, Sybil A McAuley, et al.
Diabetes Technology & Therapeutics|December 22, 2020
Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily InjectionsSybil A McAuley, Sara Vogrin, Melissa H Lee, et al.
Pageof 6